Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma. Ansell SM, Radford J, Connors JM, Dlugosz-Danecka M, et al. N Engl J Med 2022 Jul 13. doi: 10.1056/NEJMoa2206125.

Read + Share

Amedeo Smart

Independent Medical Education

Ansell SM, Radford J, Connors JM, Dlugosz-Danecka M, et al. Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma. N Engl J Med 2022 Jul 13. doi: 10.1056/NEJMoa2206125.
PMID: 35830649